CLOSE MENUIndependent, academic experts are key voices in the drug spending debate, but it can be challenging for policymakers and the media, much less the public, to hear directly from multiple experts on a single topic.
VIEW MEMBERSExpert on health care pricing, policy, and management.
view profileResearch has focused on economic issues in healthcare.
view profileWritten extensively on the pricing, demand, and supply of prescription drugs.
view profileFocused on increasing access to healthcare, with specific attention to reducing prescription drug costs.
view profileFocused on measuring and evaluating population-level use and costs of medications in the USA.
view profileFocused on the economics of mental health and substance abuse care, long term care financing policy, implementation of health reform and disability policy.
view profileFocused on the interaction of intellectual property law, food and drug regulation, and health law.
view profileFocused on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes.
view profileFocused on improving pharmaceutical coverage, affordability, and access for older adults and individuals living with chronic conditions.
view profileCIDSA’s expert panel surveys use a simplified two-stage Delphi survey methodology. In the first stage, experts are presented with a description of the policy and asked to evaluate that policy on standardized metrics; the experts also suggest areas where more information is needed to evaluate the policy. In the second round, the experts once again evaluate the policy on the same metrics, but this time with an anonymous summary of how their peers evaluated the policy in the first round.
